In re Akers Biosciences, Inc. Sec. Litig., No. 18-cv-10521 (ES) (CLW)

The Rosen Law Firm was sole lead counsel in this consolidated class action in U.S. District Court for the District of New Jersey. The complaint alleged violations of §§10b and 20(a) of the Securities Exchange Act arising out of the Company’s issuance of materially false and misleading business information. The parties agreed to settle this action for $2.25 million in cash.

Scroll to Top